Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance of the ThecaFlex DRx™ System Port and Catheter for Chronic Intrathecal Access, Cerebrospinal Fluid (CSF) Aspiration, and DElivery of Nusinersen in Spinal Muscular Atrophy (SMA) Patients Resistant to Lumbar PunctuRE Trial (PIERRE)

NCT05866419 is registered in ClinicalTrials.gov with Alcyone Therapeutics, Inc as lead sponsor.

NCT NCT05866419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05866419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance of the ThecaFlex DRx™ System Port and Catheter for Chronic Intrathecal Access, Cerebrospinal Fluid (CSF) Aspiration, and DElivery of Nusinersen in Spinal Muscular Atrophy (SMA) Patients Resistant to Lumbar PunctuRE Trial (PIERRE)
Lead sponsor
Alcyone Therapeutics, Inc
Phase
Not applicable
Overall status
Recruiting
Start date
November 27, 2023
Completion date
July 31, 2030
Enrollment
90 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

scoliosis, spinal muscular atrophy, spine deformity